- Home
- NTHI vs OMI Comparison
NTHI vs OMI Comparison
Compare NTHI & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | OMI |
|---|---|---|
| Founded | 2008 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.5M | 214.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NTHI | OMI |
|---|---|---|
| Price | $8.33 | $2.73 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.46 |
| AVG Volume (30 Days) | 64.2K | ★ 1.9M |
| Earning Date | 02-19-2026 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $59,990.00 | ★ $10,768,859,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 132.03 |
| 52 Week Low | $3.20 | $2.38 |
| 52 Week High | $25.00 | $15.54 |
Technical Indicators
Market Signals| Indicator | NTHI | OMI |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 40.96 |
| Support Level | $8.16 | $2.60 |
| Resistance Level | $10.44 | $2.79 |
| Average True Range (ATR) | 0.95 | 0.19 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 45.79 | 31.93 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.